Company name: Pharmaceutical Laboratory in Brazil
Description: Operator of a pharmaceutical laboratory in Brazil. The company holds controlled substances import licenses and quality control facilities for drug development plans for CBD and its clinical trials protocols for testing a proprietary THC/CBD gel caps formulation targeted at sleep disorders treatment.
Industry: Healthcare | Group: Healthcare Services | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company reached a definitive agreement to be acquired by Verdemed for an undisclosed amount on October 2, 2018.
Number of active investors:
Profile last updated: 03-Oct-2018
Last known valuation:
Last known valuation date: